Effects of Sertraline on Brain Connectivity in Adolescents With OCD

NCT02797808 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2021-01-05

Study results available
· View outcomes & findings →

Summary

The investigators will examine how treatment with sertraline for 12 weeks impacts frontal-striatal-thalamic circuitry (FSTC) in this OCD sample.

Conditions

  • OCD

Interventions

DRUG

Sertraline

Impact of sertraline on functional brain connectivity

OTHER

No Intervention

Healthy control non-intervention

Sponsors & Collaborators

Principal Investigators

  • Gail A Bernstein, MD · University of Minnesota

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02797808 on ClinicalTrials.gov